These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 9191171)

  • 61. Dissimilar background genes control susceptibility to autoimmune disease in the context of different MHC haplotypes: NOD.H-2(s) congenic mice are relatively resistant to both experimental autoimmune encephalomyelitis and type I diabetes.
    Greve B; Reddy J; Waldner HP; Sobel RA; Kuchroo VK
    Eur J Immunol; 2004 Jul; 34(7):1828-38. PubMed ID: 15214031
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Interactions between peptides and major histocompatibility complex molecules].
    Choppin J
    Pathol Biol (Paris); 1992 Mar; 40(3):257-64. PubMed ID: 1376892
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Peptide therapy for diabetes.
    Jones DB; Armstrong NW
    Lancet; 1994 May; 343(8906):1168-9. PubMed ID: 7910263
    [No Abstract]   [Full Text] [Related]  

  • 64. Autoimmune syndromes in major histocompatibility complex (MHC) congenic strains of nonobese diabetic (NOD) mice. The NOD MHC is dominant for insulitis and cyclophosphamide-induced diabetes.
    Wicker LS; Appel MC; Dotta F; Pressey A; Miller BJ; DeLarato NH; Fischer PA; Boltz RC; Peterson LB
    J Exp Med; 1992 Jul; 176(1):67-77. PubMed ID: 1613467
    [TBL] [Abstract][Full Text] [Related]  

  • 65. A new look at MHC and autoimmune disease.
    Ridgway WM; Fassò M; Fathman CG
    Science; 1999 Apr; 284(5415):749, 751. PubMed ID: 10336398
    [No Abstract]   [Full Text] [Related]  

  • 66. Properties of HLA class II molecules divergently associated with Goodpasture's disease.
    Phelps RG; Jones V; Turner AN; Rees AJ
    Int Immunol; 2000 Aug; 12(8):1135-43. PubMed ID: 10917888
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Protooncogenes and autoimmunity.
    Rapoport M; Mor A; Bistritzer T; Ramot Y; Levi O; Slavin S; Wysenbeek A
    Isr J Med Sci; 1997 Apr; 33(4):262-6. PubMed ID: 9347876
    [No Abstract]   [Full Text] [Related]  

  • 68. A mechanism for the major histocompatibility complex-linked resistance to autoimmunity.
    Schmidt D; Verdaguer J; Averill N; Santamaria P
    J Exp Med; 1997 Oct; 186(7):1059-75. PubMed ID: 9314555
    [TBL] [Abstract][Full Text] [Related]  

  • 69. MHC class I and autoimmune diabetes.
    Faustman DL
    Biomed Pharmacother; 1993; 47(1):3-10. PubMed ID: 7872965
    [TBL] [Abstract][Full Text] [Related]  

  • 70. An HLA-DRB1-derived peptide associated with protection against rheumatoid arthritis is naturally processed by human APCs.
    Snijders A; Elferink DG; Geluk A; van Der Zanden AL; Vos K; Schreuder GM; Breedveld FC; de Vries RR; Zanelli EH
    J Immunol; 2001 Apr; 166(8):4987-93. PubMed ID: 11290778
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Primary biliary cirrhosis associated with HLA-DRw3.
    Ercilla G; Parés A; Arriaga F; Bruguera M; Castillo R; Rodés J; Vives J
    Tissue Antigens; 1979 Nov; 14(5):449-52. PubMed ID: 12731577
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The role of MHC class II molecules in the pathogenesis and prevention of Type I diabetes.
    McDevitt H
    Adv Exp Med Biol; 2001; 490():59-66. PubMed ID: 11505975
    [No Abstract]   [Full Text] [Related]  

  • 73. Induction of diabetes in standard mice by immunization with the p277 peptide of a 60-kDa heat shock protein.
    Elias D; Marcus H; Reshef T; Ablamunits V; Cohen IR
    Eur J Immunol; 1995 Oct; 25(10):2851-7. PubMed ID: 7589082
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Peptides derived from murine insulin are diabetogenic in both rats and mice, but the disease-inducing epitopes are different: evidence against a common environmental cross-reactivity in the pathogenicity of type 1 diabetes.
    Heath VL; Hutchings P; Fowell DJ; Cooke A; Mason DW
    Diabetes; 1999 Nov; 48(11):2157-65. PubMed ID: 10535449
    [TBL] [Abstract][Full Text] [Related]  

  • 75. A new model defines the minimal set of polymorphism in HLA-DQ and -DR that determines susceptibility and resistance to autoimmune diabetes.
    Parry CS; Brooks BR
    Biol Direct; 2008 Oct; 3():42. PubMed ID: 18854049
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Associations of human leukocyte antigens with autoimmune diseases: challenges in identifying the mechanism.
    Miyadera H; Tokunaga K
    J Hum Genet; 2015 Nov; 60(11):697-702. PubMed ID: 26290149
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Self peptides isolated from MHC glycoproteins of non-obese diabetic mice.
    Reich EP; von Grafenstein H; Barlow A; Swenson KE; Williams K; Janeway CA
    J Immunol; 1994 Mar; 152(5):2279-88. PubMed ID: 8133041
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Analysis of T-cell receptor beta of the T-cell clones reactive to the human PDC-E2 163-176 peptide in the context of HLA-DR53 in patients with primary biliary cirrhosis.
    Ichiki Y; Shimoda S; Hara H; Shigematsu H; Nakamura M; Hayashida K; Ishibashi H; Niho Y
    Hepatology; 1997 Sep; 26(3):728-33. PubMed ID: 9303504
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Therapeutic intervention in autoimmunity.
    Tisch R; Yang XD; McDevitt HO
    Behring Inst Mitt; 1994 Jul; (94):171-8. PubMed ID: 7998910
    [No Abstract]   [Full Text] [Related]  

  • 80. The immune response in individuals with HLA-DR specificities conferring susceptibility to insulin-dependent diabetes--a hypothesis.
    Papadopoulos G; Lernmark A
    Diabetes Res; 1984 May; 1(1):3-11. PubMed ID: 6085044
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.